These drugs will have so many “off-label” benefits and they need to be easier and cheaper to procure
Kate CroweSuoer intrigued by GLP-1 anti inflammatory impacts on autoimmune conditions. Since I have a lot of family history of different endochrine conditions I was aware of research showing diabetes and Alzheimers' relationships to inflammation and this new research is very exciting!